Summit Therapeutics Inc (NASDAQ: SMMT) on Tuesday, soared 4.70% from the previous trading day, before settling in for the closing price of $18.3. Within the past 52 weeks, SMMT’s price has moved between $15.55 and $36.91.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -10.52%. The company achieved an average annual earnings per share of -344.72%. With a float of $96.87 million, this company’s outstanding shares have now reached $744.44 million.
Summit Therapeutics Inc (SMMT) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Summit Therapeutics Inc is 86.96%, while institutional ownership is 13.58%. The most recent insider transaction that took place on Oct 21 ’25, was worth 9,999,983. In this transaction Director of this company bought 533,617 shares at a rate of $18.74, taking the stock ownership to the 32,057,147 shares. Before that another transaction happened on Oct 21 ’25, when Company’s Co-Chief Executive Officer bought 26,680 for $18.74, making the entire transaction worth $499,983. This insider now owns 76,680 shares in total.
Summit Therapeutics Inc (SMMT) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -0.06 earnings per share (EPS) for the period topping the consensus outlook (set at -0.06) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -344.72% per share during the next fiscal year.
Summit Therapeutics Inc (NASDAQ: SMMT) Trading Performance Indicators
Summit Therapeutics Inc (SMMT) is currently performing well based on its current performance indicators. A quick ratio of 3.80 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.24, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.90 in one year’s time.
Technical Analysis of Summit Therapeutics Inc (SMMT)
The latest stats from [Summit Therapeutics Inc, SMMT] show that its last 5-days average volume of 2.86 million was inferior to 3.78 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 59.64%.
During the past 100 days, Summit Therapeutics Inc’s (SMMT) raw stochastic average was set at 19.43%, which indicates a significant decrease from 62.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.83 in the past 14 days, which was lower than the 1.41 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.11, while its 200-day Moving Average is $22.28. Now, the first resistance to watch is $19.52. This is followed by the second major resistance level at $19.88. The third major resistance level sits at $20.56. If the price goes on to break the first support level at $18.48, it is likely to go to the next support level at $17.80. Assuming the price breaks the second support level, the third support level stands at $17.44.
Summit Therapeutics Inc (NASDAQ: SMMT) Key Stats
Market capitalization of the company is 14.23 billion based on 771,150K outstanding shares. Right now, sales total 0 K and income totals -221,320 K. The company made 0 K in profit during its latest quarter, and -231,790 K in sales during its previous quarter.
